/ Active, not recruiting临床2期 A Phase 2, Multicenter, Open Label Dose-ranging Study of Sepantronium Bromide in Patients With Relapsed/Refractory c-Myc Rearranged High-grade B-cell Lymphoma (HGBCL)
This is a multi-center Phase 2 study to determine the safety and efficacy of sepantronium bromide (SepB) in adult patients with relapsed or refractory high-grade B-cell lymphoma
100 项与 Cothera Bioscience, Inc. 相关的临床结果
0 项与 Cothera Bioscience, Inc. 相关的专利(医药)
100 项与 Cothera Bioscience, Inc. 相关的药物交易
100 项与 Cothera Bioscience, Inc. 相关的转化医学